ETF Data
IHI ETF Data
Fund Profile · Snapshot Metrics · Exposure · Technicals · Risk
IHI
ETF DataETF Data Overview
ETF pages show fund-native profile, cost, size, liquidity, exposure, technical, and risk evidence.
ETF Snapshot Data
Updated Sep 4, 2026.
| Field | Value |
|---|---|
| Fund name | iShares U.S. Medical Devices ETF |
| Issuer | — |
| Asset class | — |
| Primary exposure | — |
| Domicile | — |
| Inception date | — |
| NAV currency | — |
| CUSIP | — |
| ISIN | — |
| Field | Value |
|---|---|
| Price | $53.63 |
| Fund size | $3.01B |
| Expense ratio | — |
| Holdings count | — |
| NAV | — |
| Average volume | 2.83M |
| Distribution yield | 0.24% |
| AIQ Score | 48/100 |
ETF Holdings
Reported holdings from the latest ETF holder snapshot.
No holdings rows are available in this ETF snapshot.
ETF Exposure
Sector and country composition fields from ETF snapshots where available.
No sector exposure rows are available.
No country exposure rows are available.
Institutional Holder Snapshot
Latest downstream filing-reported holders and share-count changes for this ETF.
No downstream institutional holder rows are available for this ETF yet.
Current ETF Metrics
ETF-native fields sit beside technical and risk readings for deeper research.
| Metric | Value | Unit | As of |
|---|---|---|---|
| Expense Ratio | — | percent | Sep 4, 2026 |
| Fund Size | 3,006,845,183 | currency | Sep 4, 2026 |
| Nav | — | currency_per_share | Sep 4, 2026 |
| Average Volume | 2,829,646 | count | Sep 4, 2026 |
| Distribution Yield | — | percent | Sep 4, 2026 |
| Beta | 0.81 | ratio | Sep 4, 2026 |
| High52 | — | currency_per_share | Sep 4, 2026 |
| Low52 | — | currency_per_share | Sep 4, 2026 |
| Metric | Value | Unit | As of |
|---|---|---|---|
| Close | 53.63 | price | Sep 4, 2026 |
| Volume | 1,510,719 | volume | Sep 4, 2026 |
| Rsi14 | 40.22 | index | Sep 4, 2026 |
| MACD | 0.26 | index | Sep 4, 2026 |
| MACD Signal | 0.65 | index | Sep 4, 2026 |
| MACD Histogram | -0.34 | index | Sep 4, 2026 |
| Adx14 | 18.06 | index | Sep 4, 2026 |
| Sma50 | 53.07 | price | Sep 4, 2026 |
| Sma200 | 55.57 | price | Sep 4, 2026 |
| Atr14 | 1.04 | price | Sep 4, 2026 |
| Historical Volatility | 0.18 | percent | Sep 4, 2026 |
| Volume Ma20 | 2,270,232.65 | volume | Sep 4, 2026 |
| Metric | Value | Unit | As of |
|---|---|---|---|
| Resilience Score | 69 | score_0_100 | Sep 4, 2026 |
| Beta | 0.81 | ratio | Sep 4, 2026 |
| Volatility Annual | 20.06 | percent | Sep 4, 2026 |
| Max Drawdown | -26.24 | percent | Sep 4, 2026 |
| Sharpe Ratio | -0.82 | ratio | Sep 4, 2026 |
| Var95 | -2.07 | percent | Sep 4, 2026 |
Additional ETF Metrics
Expanded ETF structure fields appear here when the entitlement and source coverage allow them.
No additional ETF structure metrics are available.
Related Links
IHI ETF Data FAQ
What is iShares U.S. Medical Devices ETF's revenue?
iShares U.S. Medical Devices ETF's revenue is one of the core financial data points for IHI. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.
Is iShares U.S. Medical Devices ETF's revenue growing?
Revenue growth shows whether iShares U.S. Medical Devices ETF is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.
What is IHI's EPS?
IHI's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.
What is iShares U.S. Medical Devices ETF's net income?
iShares U.S. Medical Devices ETF's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.
How much free cash flow does iShares U.S. Medical Devices ETF generate?
Free cash flow shows how much cash iShares U.S. Medical Devices ETF generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.
How much cash and debt does iShares U.S. Medical Devices ETF have?
Cash and debt help frame IHI's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.